CARB-X Awards DZD $6.2M to Develop New Test To Diagnose Deadly Superbug Infections
May 11 2020

Funding award is the first whole genome sequencing and machine learning technology in CARB-X portfolio

Read More
New Genomic Tests Aim to Diagnose Deadly Infections Faster
February 24 2020

DZD included in the new class of diagnostics for infectious diseases

Read More
Diagnostic Startups Take on Growing Threat of Antibiotic-Resistant Bugs
January 14 2020

DZD featured in WSJ review of emerging diagnostic companies

Read More
Genomics Links Fecal Transplant Recipient Infections to Drug-Resistant E. coli Donor
October 31 2019

EpiXact uses sequencing to confirm cause of patient death in a clinical trial with wide ranging implications

Read More
HBS Impact – Advancing Diagnostics That Can Save Lives
September 1 2019

DZD featured in Harvard Business School alumni publication on Life Lab ventures

Read More
AI Algorithm to Fight HAI Gets Support with NIH Award
July 10 2019

DZD funding award for hospital-acquired infection technology reviewed by HCIT

Read More